Back to results
US 2026/0258445 A1Published application
Recombinant adeno-associated viral vector for gene delivery
AssigneeAbeona Therapeutics Inc.
InventorsTimothy J. MILLER, Linas PADEGIMAS
Life of this patent
Estimating the term…
Abstract
Provided herein are recombinant AAV vectors, AAV viral vectors, and capsid proteins for improved gene therapy, and methods for their manufacture and use.
Claims22
-28. (canceled)
A method of treating an eye disease or disorder in a subject in need thereof, comprising administering an adeno-associated virus (AAV) viral vector to an eye of the subject, wherein the AAV viral vector comprises an AAV capsid protein comprising an amino acid sequence of SEQ ID NO:
- 2.
An AAV capsid protein comprising an amino acid sequence of SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.